share_log

Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Benzinga ·  17:48

Shares of Intel Corporation (NASDAQ:INTC) rose sharply in today's pre-market trading after the company announced a strategic collaboration with AWS to help advance US-based chip manufacturing.

Intel shares jumped 6.9% to $22.36 in the pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) gained 73.1% to $6.70 in pre-market trading after declining around 6% on Monday.
  • Smith Micro Software, Inc. (NASDAQ:SMSI) rose 62.4% to $0.8499 in today's pre-market trading after declining around 9% on Monday.
  • Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) gained 36.7% to $10.05 in the pre-market trading session after jumping 35% on Monday.
  • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 21.3% to $4.10 in pre-market trading.
  • Adagio Medical Holdings, Inc. (NASDAQ:ADGM) rose 16.5% to $4.81 in pre-market trading.
  • Healthy Choice Wellness Corp. (NASDAQ:HCWC) rose 14.5% to $6.00 in pre-market trading after dipping 48% on Monday.
  • Mynaric AG (NASDAQ:MYNA) gained 13.9% to $0.90 in pre-market trading after gaining 13% on Monday.
  • SciSparc Ltd. (NASDAQ:SPRC) shares rose 12% to $0.3490 in pre-market trading. SciSparc-Clearmind Medicine collaboration announced the publication of an international patent application for pioneering ibogaine combination therapy.
  • Avinger, Inc. (NASDAQ:AVGR) gained 10.5% to $1.47 in pre-market trading after the company announced it will be issued the U.S. patent number 12,089,868 for the treatment of occlusive coronary artery disease.

Losers

  • Netcapital Inc. (NASDAQ:NCPL) fell 33% to $1.93 in pre-market trading after reporting first-quarter earnings results.
  • NKGen Biotech, Inc. (NASDAQ:NKGN) shares dipped 19.4% to $0.60 in pre-market trading after declining around 4% on Monday. NKGen Biotech, last week, announced early interim data from the Phase 1 cohort and the dosing of the first Phase 2 patient in the Phase 1/2a clinical trial of troculeucel.
  • Dermata Therapeutics, Inc. (NASDAQ:DRMA) fell 14.2% to $1.99 in pre-market trading after the company announced a $3.5 million private placement priced at-the-market under Nasdaq rules.
  • Golden Heaven Group Holdings Ltd. (NASDAQ:GDHG) shares fell 12.7% to $0.0916 in pre-market trading after gaining 5% on Monday.
  • Bone Biologics Corporation (NASDAQ:BBLG) shares declined 12.7% to $1.65 in pre-market trading after jumping 136% on Monday.
  • CN Energy Group. Inc. (NASDAQ:CNEY) shares fell 11.6% to $0.42 in pre-market trading after gaining around 6% on Monday. CN Energy, last week, announced it received a noncompliance notice from the Nasdaq.
  • Ocean Power Technologies, Inc. (NASDAQ:OPTT) shares declined 9.6% to $0.2259 in pre-market trading following quarterly results.
  • Aptevo Therapeutics Inc. (NASDAQ:APVO) fell 9.1% to $0.30 in today's pre-market trading after announcing a $3.0 million offering priced at-the-market under Nasdaq rules.
  • Tenon Medical, Inc. (NASDAQ:TNON) shares fell 8.7% to $7.04 in pre-market trading.
  • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) declined 7.2% to $2.21 in pre-market trading after gaining around 9% on Monday.

Now Read This:

  • 'If You Want Steel, You Do Nucor,' Says Cramer When Asked About Gerdau
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment